CLINICAL_TRIALS
research
· 2026-01-20
Clinical Trial Update: Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry
Summary
Completed status for the Paroxysmal nocturnal hemoglobinuria (PNH) Registry, an observational study sponsored by Alexion Pharmaceuticals to track patient outcom…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Paroxysmal Nocturnal Hemoglobinuria | Status: COMPLETED